Actually, O/S is still as it was before--a tick under 2B. The A/S, which was actually confirmed by the company in their filings and release last week was raised to assist with paying for Min science, incrementally.
I hardly think paying for a ground-breaking cancer combating treatment is "dumping shares".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.